Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Practice Economics
Doctors to APM committee: Remember specialists
Publish date:
February 2, 2016
References
On Twitter
@legal_med
Pages
« first
1
2
Recommended Reading
NIH, CDC get boost in House budget bill
MDedge Hematology and Oncology
ACA marketplace sees late surge in new enrollees
MDedge Hematology and Oncology
Congress passes ACA repeal bill; President says he will veto
MDedge Hematology and Oncology
President vetoes bill to repeal ACA
MDedge Hematology and Oncology
CMS: End of meaningful use imminent in 2016
MDedge Hematology and Oncology
Alternative payment models: MedPAC says keep it simple
MDedge Hematology and Oncology
Law & Medicine: Health care costs and defensive medicine
MDedge Hematology and Oncology
CMS: IT changes are coming, but not here yet
MDedge Hematology and Oncology
Consensus document issued on hematology research priorities for Europe
MDedge Hematology and Oncology
Medicare to cover HSCT in approved clinical trials for myeloma, myelofibrosis, sickle cell disease
MDedge Hematology and Oncology
Practice Management
Business of Medicine
All Specialties
